Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, the FDA issued a Warning Letter to Yahon Enterprise Co., Ltd., a drug manufacturer, on June 5, 2024. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug regulatory authority, though the issuing office is not specified in the metadata provided. Additional details about the compliance deficiencies would require review of the complete Warning Letter document.